AMWL
American Well CorpPrice
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- Mar 2 ▼ 4 insiders sell $89.4K at $5.27
- Apr 1 ▼ 3 insiders sell $51.2K at $5.30
- May 7 ▲ 1 insider buy $4.9K at $7.37
- May 18 ▲ Amwell announced results from a large NIH-funded randomized trial pu…
- May 18 FDA: Nature Human Behaviour study finds SilverCloud® by Amwell®…
- Jun 1 ▼ 3 insiders sell $140.7K at $9.74
- Jun 11 ▼ 1 insider sell $85.4K at $8.76
- Jul 1 ▼ 4 insiders sell $187.4K at $9.33
- Aug 4 Amwell Q2 2026 revenue of $52.0M was at the top end of guidance, but…
- Sep 1 ▼ 3 insiders sell $170.3K at $11.80
- Sep 8 Contract: Amwell Receives Letter of Intent from Department of Vetera…
- Oct 1 ▼ 4 insiders sell $260.7K at $13.00
Signal stack
Where each data set points today.
- InsidersBEARISH
1 insider bought $4.9K at an average $7.37. 5 insiders sold $985.3K. Price is 54% above their cost.
- InstitutionsMIXED
Q3 2026: 7 added (0 new), 5 trimmed or exited.
- AnalystsBULLISH
6 of 15 rate it Buy or better. Every target is above the price.
- EstimatesRISING
Current-quarter EPS estimate −$0.440 → −$0.350 over 90 days. 1 up, 0 down in 30 days.
- Short sellersBUILDING
Short interest +21.1% to 250.2K shares. 1.7 days to cover, ≈1.4% of shares.
- TrendDOWNTREND
12% below its 50-day average.
Who's buying
13F· Q3 2026| Fund | Move | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | ADD | $5.4M |
| MARSHALL WACE, LLP | DOUBLED | $4.8M |
| BlackRock, Inc. | TRIM | $4.3M |
| JANE STREET GROUP, LLC | TRIM | $543.9K |
| AMERICAN CENTURY COMPANIES INC | ADD | $258.3K |
| IMC-Chicago, LLC | ADD | $221.5K |
| JPMORGAN CHASE & CO | DOUBLED | $113.5K |
| UBS Group AG | NEAR_EXIT | $68.7K |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
15 analystsPrice is below the lowest target. Median implies +15%.Targets as of Nov 17, 2026.
| Date | Firm | Rating |
|---|---|---|
| Nov 4, 2026 | TD Cowen MAINTAIN | Hold |
| Nov 4, 2026 | Wells Fargo MAINTAIN | Overweight |
| Nov 4, 2026 | Stifel MAINTAIN | Hold |
| Aug 13, 2026 | Truist Securities MAINTAIN | Hold |
| Aug 5, 2026 | Needham REITERATE | Hold |
| Jul 17, 2026 | Wells Fargo MAINTAIN | Overweight |
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
McNeice Paul Francis Chief Accounting Officer Oct 1, 2026 | SELL | $8.5K |
Zamansky Dmitry Chief Product & Tech. Officer Oct 1, 2026 | SELL | $109.7K |
HIRSCHHORN MARK Chief Financial Officer Oct 1, 2026 | SELL | $55.7K |
Gotlib Phyllis President, International Oct 1, 2026 | SELL | $86.8K |
HIRSCHHORN MARK Chief Financial Officer Sep 1, 2026 | SELL | $126.9K |
McNeice Paul Francis Chief Accounting Officer Sep 1, 2026 | SELL | $1.3K |
Gotlib Phyllis President, International Sep 1, 2026 | SELL | $42.2K |
Zamansky Dmitry Chief Product & Tech. Officer Jul 1, 2026 | SELL | $78.9K |
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | -$0.35 | -$0.35–-$0.35 | +20.5% | $49.3M |
| Next Q | -$0.49 | -$0.65–-$0.26 | +8.5% | $54.7M |
| Current FY | -$2.46 | -$2.46–-$2.46 | +3.9% | $205.2M |
| Next FY | 🔒 Fresh data, subscribers only | |||
Short side
FINRA· Oct 30, 2026SecBot reports
17 filings · 1 press release · 0 bullish · 1 bearish · 2 mixed · 14 neutral- NEUTRAL DEFA14ANov 13, 2026
Amwell filed additional definitive proxy soliciting materials (DEFA14A) urging shareholders to…
Monitor the special meeting outcome on December 29. If approved, the additional shares will be available for equity grants over the next year, which could support retention but also increase…
- NEUTRAL DEF 14ANov 13, 2026
Amwell is seeking shareholder approval at a December 29, 2026 special meeting to increase shares…
Monitor the special meeting vote outcome on December 29, 2026. If approved, the company will file an S-8 registration statement for the additional shares. The proxy also serves as a reference for…
- NEUTRAL 8-KNov 3, 2026
Amwell reported Q3 2026 revenue of $49.0M, above the $47.3M consensus, but GAAP net loss widened…
Monitor Q4 2026 results for achievement of positive cash flow from operations, which would mark a key inflection point. The raised full-year guidance and narrowing adjusted EBITDA losses suggest…
- NEUTRAL CLUSTEROct 5, 2026
Two AMWL insiders, including the Chief Product & Technology Officer, sold shares totaling $118K in…
Insider sales are small and routine in dollar terms. No material signal, monitor next earnings for any fundamental changes.
All AMWL filing & press-release reports (18)
- DEFA14A reportNov 13, 2026
- DEF 14A reportNov 13, 2026
- 8-K reportNov 3, 2026
- CLUSTER reportOct 5, 2026
- 144 reportOct 1, 2026
- CLUSTER reportSep 3, 2026
- 8-K reportAug 4, 2026
- 144 reportJul 1, 2026
- CLUSTER reportJul 1, 2026
- DEFA14A reportJun 9, 2026
- CLUSTER reportJun 3, 2026
- 144 reportJun 1, 2026
- PRESS-RELEASE reportMay 18, 2026
- 8-K reportMay 12, 2026
- 8-K reportMay 5, 2026
- DEFA14A reportApr 23, 2026
- CLUSTER reportMar 2, 2026
- CLUSTER reportMar 2, 2026